Peter Thiel's Fund Exits ETHZilla

- ETHZilla was formerly a biotech company named 180 Life Sciences before it pivoted to an Ethereum-hoarding strategy modeled after MicroStrategy's approach to Bitcoin. - The firm's stock reached an all-time high of nearly $107 in August 2025 before collapsing to under $5 by the end of the year, a 95% drop that forced the company to sell over $114 million in ETH to service debt. - Founders Fund has a track record of profitable crypto exits, having previously invested $15-20 million in Bitcoin before its 2017 bull run and selling its holdings for $1.8 billion prior to the 2022 market downturn. - Harvard's investment was made through its Harvard Management Company (HMC), which manages a $56.9 billion endowment. Despite trimming its Bitcoin ETF holdings by 21%, the remaining $265.8 million stake is still the university's largest publicly disclosed equity holding. - The new lending options on Coinbase for XRP and DOGE come with stricter risk controls, including a $100,000 borrowing cap and a 49% maximum loan-to-value ratio, compared to 75% for Bitcoin. The service runs through the Morpho protocol on Coinbase's layer-two network, Base. - The recent accumulation by Bitcoin whales occurred over approximately two months since mid-December 2025, increasing their total holdings from 2.9 million to 3.1 million BTC. A similar accumulation pattern in April 2025 preceded a major market rally. - The Injective protocol's "Volan" upgrade introduced a module for Real World Assets (RWAs), designed to allow institutions to issue permissioned, compliant tokens on the blockchain. It also included significant enhancements to its cross-chain communication capabilities. - The poor performance of many tokens launched in 2025 occurred during a wider market downturn in the latter part of the year, which saw Bitcoin correct by roughly 32% from its October peak. However, some niche crypto assets, such as privacy coins and gold-backed stablecoins, posted significant gains during the same period.